跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Remifen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Remifen
Approved
STANDARD
Remifen
Laboratorios Normon, S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9e499ab1bd524d7a
Company
Laboratorios Normon, S.A.
Type
Standard
Approval Details
Approval Id
9e499ab1bd524d7a
Drug Approval Philippines Name
Remifen
Product Name
Remifen
Registration Number
DR-XY48104
Brand Name
Remifen
Generic Name
Remifentanil (as hydrochloride)
Dosage Form
Lyophilized Powder for Solution for Injection or Infusion (IV)
Dosage Strength
1 mg
Manufacturer
Laboratorios Normon, S.A.
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Company Detail Path
/organization/laboratorios-normon-sa
Issuance Date
26 August 2022
Expiry Date
26 August 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9e499ab1bd524d7a
Type
Standard
Back to Philippines FDA Approvals